Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS
Stacey M. Frumm, Shai Shimony, Richard M. Stone, Daniel J. DeAngelo, Jan Phillipp Bewersdorf, Amer M. Zeidan, Maximilian Stahl
Topics & Concepts
MedicineMyelodysplastic syndromesDrug developmentClinical trialDiseaseIntensive care medicineDrugOncologyBioinformaticsInternal medicinePharmacologyBone marrowBiologyAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments